Gene · 6891
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SNPs in 3'UTR miRNA Target Sequences Associated with Individual Drug Susceptibility. | Int J Mol Sci | 2022 | 36430200 | PubTator, text mining | PubMed |
| Isolated BAP1 Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic Response. | Cancers (Basel) | 2022 | 36428720 | PubTator, text mining | PubMed |
| The Mechanisms of Fur Development and Color Formation in American Mink Revealed Using Comparative Transcriptomics. | Animals (Basel) | 2022 | 36428316 | PubTator, text mining | PubMed |
| Structure and evolution of the squamate major histocompatibility complex as revealed by two Anolis lizard genomes. | Front Genet | 2022 | 36425073 | PubTator, text mining | PubMed |
| Translatomic response of retinal Müller glia to acute and chronic stress. | Neurobiol Dis | 2022 | 36423879 | PubTator, text mining | PubMed |
| The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation. | Front Oncol | 2022 | 36419887 | PubTator, text mining | PubMed |
| Interferon partly dictates a divergent transcriptional response in poxvirus-infected and bystander inflammatory monocytes. | Cell Rep | 2022 | 36417857 | PubTator, text mining | PubMed |
| Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy. | J Exp Clin Cancer Res | 2022 | 36397155 | PubTator, text mining | PubMed |
| MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil. | Front Immunol | 2022 | 36389712 | PubTator, text mining | PubMed |
| CTCF blocks antisense transcription initiation at divergent promoters. | Nat Struct Mol Biol | 2022 | 36369346 | PubTator, text mining | PubMed |
| The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. | Int J Mol Sci | 2022 | 36362359 | PubTator, text mining | PubMed |
| The Role of Epigenetics in the Development and Progression of Multiple Myeloma. | Biomedicines | 2022 | 36359286 | PubTator, text mining | PubMed |
| Post-Translational Modifications by Lipid Metabolites during the DNA Damage Response and Their Role in Cancer. | Biomolecules | 2022 | 36359005 | PubTator, text mining | PubMed |
| The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy. | Cancers (Basel) | 2022 | 36358715 | PubTator, text mining | PubMed |
| Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells. | Front Immunol | 2022 | 36341354 | PubTator, text mining | PubMed |
| Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma. | Front Immunol | 2022 | 36341345 | PubTator, text mining | PubMed |
| The transcriptional characteristics of NADC34-like PRRSV in porcine alveolar macrophages. | Front Microbiol | 2022 | 36338035 | PubTator, text mining | PubMed |
| Human variation in population-wide gene expression data predicts gene perturbation phenotype. | iScience | 2022 | 36310583 | PubTator, text mining | PubMed |
| Exogenous Nitric Oxide Alleviates the Damage Caused by Tomato Yellow Leaf Curl Virus in Tomato through Regulation of Peptidase Inhibitor Genes. | Int J Mol Sci | 2022 | 36293408 | PubTator, text mining | PubMed |
| Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes. | Int J Mol Sci | 2022 | 36293188 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6891/papers?page=19